As at Nov 21, 2024, the MEDP stock has a price-to-earnings ratio of 28.89. This is based on the current EPS of $11.83 and the stock price of $341.82 per share. A decrease of 17% has been recorded in the PE ratio compared to the average of 34.7 of the last four quarters.
The mean historical PE ratio of Medpace Holdings over the last nine years is 41.51. The current 28.89 P/E ratio is 30% lower than the historical average. In the past nine years, MEDP's PE ratio peaked in the Sep 2016 quarter at 248.83, with a price of $29.86 and an EPS of $0.12. The Mar 2023 quarter marked the lowest point at 22.99, with a price of $188.05 and an EPS of $8.18.
Maximum annual increase: 25.76% in 2021
Maximum annual decrease: -61.8% in 2017
Year | PE ratio | Change |
---|---|---|
2023 | 33.32 | 18.75% |
2022 | 28.06 | -34.76% |
2021 | 43.01 | 25.76% |
2020 | 34.2 | 13.51% |
2019 | 30.13 | 16.69% |
2018 | 25.82 | -28.79% |
2017 | 36.26 | -61.8% |
2016 | 94.92 | N/A |
2015 | N/A | N/A |
The current PE ratio of MEDP is lower than the 3 and 5-year averages.
In comparison to its peer stock ORMP, MEDP's PE ratio is higher.
Stock name | PE ratio | Market cap |
---|---|---|
ORMP Oramed Pharmaceuticals Inc | 21 | $93.12M |
MEDP Medpace Holdings Inc | 28.89 | $10.62B |
OLMA Olema Pharmaceuticals Inc | N/A | $450.93M |
OMER Omeros Corp | N/A | $447.95M |
OMGA Omega Therapeutics Inc | N/A | $42.96M |
ONCT Oncternal Therapeutics Inc | N/A | $3.43M |
ONVO Organovo Holdings Inc | N/A | $5.38M |
ORIC Oric Pharmaceuticals Inc | N/A | $643.57M |
The price to earnings ratio for MEDP stock is 28.89 as of Nov 21, 2024.
As an average over the last 3 years, MEDP stock has a PE ratio of 30.43.
As an average over the last 5 years, MEDP stock has a PE ratio of 31.34.
The highest quarterly PE ratio in the last nine years has been 248.83 and it was in the Sep 2016 quarter.
MEDP's current price to earnings ratio is 30% below its 9-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Nov 21, 2024), Medpace Holdings's stock price is $341.82. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $11.83. Therefore, Medpace Holdings's PE ratio for today is 28.89. PE RATIO(28.89) = STOCK PRICE($341.82) / TTM EPS($11.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.